1. Efficacy of Rhino-Protect ointment after endoscopic sinus surgery: a prospective, randomized, multicenter study
- Author
-
Soo Whan Kim, Kyu-Sup Cho, Chang Hoon Kim, and Jin Kook Kim
- Subjects
Adult ,Male ,medicine.medical_specialty ,Chronic rhinosinusitis ,medicine.medical_treatment ,Nostril ,Ointments ,03 medical and health sciences ,Postoperative Complications ,0302 clinical medicine ,Edema ,Paranasal Sinuses ,otorhinolaryngologic diseases ,Humans ,Medicine ,Prospective Studies ,Sinusitis ,skin and connective tissue diseases ,030223 otorhinolaryngology ,Adverse effect ,Aged ,Rhinitis ,business.industry ,Endoscopy ,General Medicine ,Middle Aged ,Otorhinolaryngologic Surgical Procedures ,Surgery ,Endoscopic sinus surgery ,Treatment Outcome ,medicine.anatomical_structure ,Otorhinolaryngology ,Nasal spray ,Multicenter study ,030220 oncology & carcinogenesis ,Chronic Disease ,Female ,medicine.symptom ,business ,After treatment - Abstract
Blocking airflow into the sinonasal cavity after surgery may help to keep the cavity moist and thus decrease postoperative crusting. Here we investigated the efficacy of Rhino-Protect ointment following endoscopic sinus surgery (ESS). A total of 93 patients with chronic rhinosinusitis who underwent identical ESS were enrolled. After surgery, all patients were instructed to perform nasal saline irrigation and deliver a nasal spray to each nostril, then to apply Rhino-Protect ointment to one nostril only; the other nostril served as a control. Subjective symptoms, postoperative Lund–Kennedy (LK) endoscopic scores, and adverse reactions 14 and 28 days after treatment were evaluated. The Rhino-Protect ointment significantly reduced pain (p = 0.015 at 28 days), dryness (p = 0.009 at 14 days and p = 0.045 at 28 days), and crusting (p = 0.047 at 14 days), and was associated with significantly lower LK scores 14 and 28 days after treatment (p = 0.037 and p = 0.007, respectively). Statistically significant differences were noted in the LK edema subscore at 14 days (p = 0.043) and in LK crusting subscores at 14 and 28 days (p = 0.005 and p = 0.006, respectively). No patient reported any serious adverse event associated with Rhino-Protect use. Applying Rhino-Protect after ESS significantly reduced the formation of edema and crusts, leading to improving the patients’ discomfort for pain, dryness, and crust.
- Published
- 2020
- Full Text
- View/download PDF